Arine Secures $29 Million To Meet High Demand For Its Medication Intelligence Platform

Aug 17, 2022•over 3 years ago

Amount Raised

$29 Million

San FranciscoInformation Technology

Description

Arine, a next-generation medication intelligence company, today announced that it has raised $29 million in Series B funding composed of equity and debt financing. The round was led by 111° West Capital, with participation from new investors MBX Capital and New Leaf Venture Partners and continued support from Katalyst Ventures and Super Capital Group.

Company Information

Company

Arine

Location

595 MARKET ST.

San Francisco, California, United States

About

Arine’s industry-leading software platform seamlessly integrates cutting-edge AI, clinical expertise, and advanced data analytics to deliver medication-based care interventions at the population level. Using Arine outcomes data, these proactive interventions are dynamically updated to provide a value-based solution that improves patient outcomes and reduces costs with unparalleled precision and efficiency.

Related People

2 contacts

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Arine Secures $29 Million To Meet High Demand For Its Medication Intelligence Platform

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information